MY177164A - Attenuated bacteria for use in a vaccine - Google Patents

Attenuated bacteria for use in a vaccine

Info

Publication number
MY177164A
MY177164A MYPI2012005702A MYPI2012005702A MY177164A MY 177164 A MY177164 A MY 177164A MY PI2012005702 A MYPI2012005702 A MY PI2012005702A MY PI2012005702 A MYPI2012005702 A MY PI2012005702A MY 177164 A MY177164 A MY 177164A
Authority
MY
Malaysia
Prior art keywords
sequences
polypeptide
relates
pasteurella
bacteria
Prior art date
Application number
MYPI2012005702A
Inventor
Abdul Rahim Raha
Zamri Bin Saad Mohd
Zakaria Zunita
Sarah Othman Siti
Original Assignee
Univ Putra Malaysia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Putra Malaysia filed Critical Univ Putra Malaysia
Priority to MYPI2012005702A priority Critical patent/MY177164A/en
Publication of MY177164A publication Critical patent/MY177164A/en

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The present invention relates to an attenuated bacterium for use as a medicament which stimulates protective immunity against normal growth of pathogenic Pasteurella bacteria. The invention also relates to immunogenic preparations including vaccines against disease caused by infection by a virulent Pasteurella strain and tools for the generation of immunological and diagnostic reagents. Further, the present invention relates to live attenuated recombinant bacteria carrying a gene and vaccines based thereon that can be administered to animals, particularly ruminants to provide protective immunity against challenge by Pasteurella bacteria. Also disclosed are the bacterium polypeptide and includes polypeptide sequences, gene sequences encoding the polypeptide, vectors to contain the said sequences, and host cells transformed with the said vectors which include nucleotide sequences of the polypeptide sequences.
MYPI2012005702A 2007-02-13 2007-02-13 Attenuated bacteria for use in a vaccine MY177164A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MYPI2012005702A MY177164A (en) 2007-02-13 2007-02-13 Attenuated bacteria for use in a vaccine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MYPI2012005702A MY177164A (en) 2007-02-13 2007-02-13 Attenuated bacteria for use in a vaccine

Publications (1)

Publication Number Publication Date
MY177164A true MY177164A (en) 2020-09-08

Family

ID=79170403

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI2012005702A MY177164A (en) 2007-02-13 2007-02-13 Attenuated bacteria for use in a vaccine

Country Status (1)

Country Link
MY (1) MY177164A (en)

Similar Documents

Publication Publication Date Title
Dhama et al. DNA vaccines and their applications in veterinary practice: current perspectives
Simionatto et al. Mycoplasma hyopneumoniae: from disease to vaccine development
Goel et al. Intradermal immunization with outer membrane protein 25 protects Balb/c mice from virulent B. abortus 544
DK2566507T3 (en) Bioconjugate vaccines with capsular gram-positive bacteria
US11103569B2 (en) Vaccine for protection against Streptococcus suis
WO2008039408A3 (en) Live bacterial vaccines for viral infection prophylaxis or treatment
MX2009006178A (en) Salmonella vaccine.
WO2005116270A3 (en) Influenza virus vaccine composition and method of use
RU2014134365A (en) CLOSTRIDIUM DIFFICILE VACCINES INCLUDING RECOMBINANT TOXINS
MX2011011186A (en) A tuberculosis tb vaccine to prevent reactivation.
Mirzaei et al. The study of H. pylori putative candidate factors for single-and multi-component vaccine development
YU102103A (en) Mycoplasma bovis vaccine and methods of reducing pneumonia in animals
BRPI0816134A2 (en) Herpesvirus, DNA sequence, vector, cell, virus, method for producing infectious particles, infectious particles, vaccine, use of herpesvirus or DNA sequence or vector or infectious particles, and method for preventive and / or treatment. treatment of a disease.
Estein et al. The polymeric antigen BLSOmp31 confers protection against Brucella ovis infection in rams
MD4481C1 (en) Recombinant Koi herpesvirus (KHV) and vaccine for the prevention of a disease caused by KHV
WO2015051371A3 (en) Haemophilus parasuis vaccine serovar type four
NZ598605A (en) Vaccine against african horse sickness virus
JP2022506634A (en) Vaccine for protection against streptococcus supra infection
Dong et al. Immune responses of mice immunized by DNA plasmids encoding PCV2 ORF 2 gene, porcine IL-15 or the both
MY177159A (en) Attenuated bacteria for use in a vaccine
MY177164A (en) Attenuated bacteria for use in a vaccine
MY168662A (en) Attenuated bacteria for use in a vaccine
MY188912A (en) Attenuated bacteria for use in a vaccine
CN104248754A (en) Streptococcus suis vaccine composition, and preparation method and application thereof
WO2008058116A3 (en) Tbpb proteins in attenuated oral live vaccines